期刊： BLOOD PURIFICATION, 2022; 51 (2)
Introduction: Cardiovascular events (CVE) remain the leading cause of mortality in hemodialysis (HD) patients. The ability to assess the risk of short......
期刊： BLOOD PURIFICATION, 2022; 51 (6)
Introduction: Membrane fouling is a significant complication potentially reducing clinical effects of extracorporeal blood purification (EBP) in criti......
期刊： BLOOD PURIFICATION, 2022; 51 (10)
The accumulation of protein-bound uremic toxins and medium-large molecule toxins in maintenance hemodialysis (MHD) patients is one of the causes of lo......
期刊： BLOOD PURIFICATION, 2022; 51 (5)
Background: Higher beat-to-beat blood pressure (BP) variation during haemodialysis (HD) has been shown to be associated with elevated cardiac damage m......
期刊： BLOOD PURIFICATION, 2022; 51 (5)
Background: Neointimal hyperplasia (NIH) is believed to be the main reason for arteriovenous fistula (AVF) dysfunction, but other mechanisms are also ......
期刊： BLOOD PURIFICATION, 2022; 51 (12)
Introduction: Continuous renal replacement therapy using regional citrate anticoagulation is commonly used as a modality of organ support in the criti......
期刊： BLOOD PURIFICATION, 2022; 51 (5)
Introduction: Data on the role of irisin in vascular calcification in patients with end-stage renal diseases on regular dialysis are inconsistent, and......
期刊： BLOOD PURIFICATION, 2022; 51 (7)
Aim: The aim of this study was to investigate the association of hyperoncotic (20%) human albumin solution (HAS) with outcomes among critically ill pa......
期刊： BLOOD PURIFICATION, 2022; 51 (3)
Introduction: The impact of early-onset peritonitis (EOP) on patients with diabetes undergoing peritoneal dialysis (PD) has not been adequately addres......
期刊： BLOOD PURIFICATION, 2022; 51 (8)
Background: Anticoagulation-free continuous renal replacement therapy (CRRT) was recommended by the current clinical guideline for patients with incre......
期刊： BLOOD PURIFICATION, 2022; 51 (4)
Background/Aim: This study mainly aimed to explore the therapeutic effects of 3 renal replacement therapy (RRT) modalities on acute kidney injury (AKI......
期刊： BLOOD PURIFICATION, 2022; 51 (9)
Introduction: Central venous catheter (CVC) as vascular access in hemodialysis (HD) associates with adverse outcomes. Early CVC to fistula or graft co......
期刊： BLOOD PURIFICATION, 2022; 51 (9)
Background: Patients with maintenance hemodialysis (MHD) generally have a microinflammatory state. The aim of this study was to investigate the effect......
期刊： BLOOD PURIFICATION, 2022; 51 (2)
Coronavirus disease (COVID-19) is highly contagious and is now a tragic pandemic. Maintenance hemodialysis (MHD) patients are susceptible to COVID-19 ......
期刊： BLOOD PURIFICATION, 2022; 51 (2)
Background: Erythropoiesis-stimulating agents (ESAs) constitute an important treatment option for anemia in hemodialysis (HD) patients. We investigate......
